Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-11

Clinical Trial Update: Repeat Ivermectin Mass Drug Administrations for MALaria Control II [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results have been posted for repeat ivermectin mass drug administrations to help control malaria. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: Brian Foy | Conditions: Malaria | Phase 3 | Status: COMPLETED | Results posted: 2024-01-11